Cyclosporin A therapy in refractory non-infectious childhood uveitis

scientific article

Cyclosporin A therapy in refractory non-infectious childhood uveitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BJO.82.7.737
P932PMC publication ID1722678
P698PubMed publication ID9924362
P5875ResearchGate publication ID13365576

P2093author name stringForrester JV
Dick AD
Kilmartin DJ
P2860cites workSystemic Uveitis Syndromes in Childhood: An Analysis of 340 CasesQ70230626
Dosage of Cyclosporin A in children with renal transplantsQ70380738
Management of pituitary-adrenal suppression secondary to corticosteroid therapyQ70806532
Behçets disease in childrenQ70939834
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitisQ70998593
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agentsQ71020371
FK506 treatment of noninfectious uveitisQ71659308
Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantationQ71695601
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's diseaseQ72042895
Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantationQ72098102
The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological studyQ72314582
Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipientsQ72326289
Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoringQ72343561
Growth after renal transplantation in prepubertal children: impact of various treatment modalitiesQ72438510
Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhoodQ72771725
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injectionQ73138186
Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory diseaseQ73211674
Endogenous uveitis in children; associated band-shaped keratopathy and rheumatoid arthritisQ73280674
Uveitis in childrenQ73318773
Neoral--new cyclosporin for old?Q73891154
Standardization of vitreal inflammatory activity in intermediate and posterior uveitisQ93559746
UVEITIS IN CHILDREN: ANALYSIS OF 274 CASESQ34204652
Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppressionQ35628600
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. IIQ36061342
Pattern of uveitis in childrenQ37335634
Immunosuppressive drugs in immune and inflammatory ocular diseaseQ37729973
Juvenile arthritis and uveitisQ37924969
Uveitis in childhood--Part I. Anterior.Q38613222
Uveitis in childhood--Part II. IntermediateQ38613224
Uveitis in childhood--Part III. PosteriorQ38613226
Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuationQ40380386
Renal transplantation in young childrenQ40441281
Changing patterns in uveitis of childhoodQ40949447
Safety aspects of cyclosporin in rheumatoid arthritis.Q41038080
International consensus recommendations on cyclosporin use in rheumatoid arthritisQ41038087
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin AQ41719098
Low dose cyclosporin A therapy in chronic posterior uveitisQ44276629
Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammationQ44621307
Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhoodQ45009477
Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.Q51032239
Pediatric intermediate uveitis.Q52533677
Plasma creatinine and urea concentration in children: Normal values for age and sexQ67452772
Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated childrenQ67757027
Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitisQ67938095
Long-term results of cyclosporin A therapy in childrenQ68009683
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune DiseasesQ68129476
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory diseaseQ69741243
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectuveitisQ280027
cyclosporineQ367700
P304page(s)737-742
P577publication date1998-07-01
P1433published inBritish Journal of OphthalmologyQ13443571
P1476titleCyclosporin A therapy in refractory non-infectious childhood uveitis
P478volume82

Reverse relations

cites work (P2860)
Q37479820A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
Q41994612An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis
Q36025876Biological response modifier therapy for refractory childhood uveitis
Q42714905Challenges of childhood uveitis
Q35580562Clinical trials in pediatric uveitis
Q44517198Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells
Q27693189Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation
Q44743074Etanercept therapy in children with treatment-resistant uveitis
Q37956187Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis
Q35711324Experience with cyclosporine in endogenous uveitis posterior
Q34070773High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis
Q36371451Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature
Q35760145Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis
Q35825121Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up
Q26749339Juvenile idiopathic arthritis-associated uveitis
Q46542282Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis
Q34574284Management of uveitis in pediatric patients: special considerations
Q36584169Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry
Q37535944Non-infectious pediatric uveitis: an update on immunomodulatory management
Q36676241Ocular complications of childhood rheumatic diseases: uveitis
Q38119243Overview and recent developments in the medical management of paediatric uveitis
Q35113997Pediatric uveitis
Q38123032Pediatric uveitis: new and future treatments
Q34374469Prognostic factors in juvenile idiopathic arthritis
Q34789195Response of pediatric uveitis to tumor necrosis factor-α inhibitors
Q35145997Special considerations in the evaluation and management of uveitis in children
Q35902397Treatment of ocular inflammation in children
Q34965097Treatment of rheumatic diseases in children: special considerations.
Q58326249Treatment strategies for childhood noninfectious chronic uveitis: an update
Q36388536Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
Q35582804Use of immunosuppressive agents in uveitis
Q38396962Uveitis associated with juvenile idiopathic arthritis
Q86322030Uveitis in Children: Diagnosis and Management
Q35591193Visual loss in uveitis of childhood
Q86108091[Therapy of intermediate uveitis]